Category: NYSE:PFE

In 2014 They Battled For Control. Now Pfizer’s Read And AstraZeneca’s Soriot In Different Places

Unfortunately, AstraZeneca’s revenue predictions have not lived up to Soriot’s promise.

After 20 Years, Abbott Labs CEO Miles White Has Successor In Mind

Abbott Laboratories CEO Miles White appears to have settled on his successor at the diversified healthcare company in medical device business head Robert Ford.

Pharma Failures Actually Advance Medicine

The fact is we want big pharma to work on these difficult challenges. No other entity can do this.

Biopharma Attacked For Excessive Profits On Drugs For Children

These laws have transformed the way medicines are developed for pediatric populations.

Harvard Professor’s Attack On Pharma’s Clinical Trials Is Absurd

Yes, we must be vigilant to be certain that studies are run ethically and that results are published accurately and on time. But, to say that academic-industry relationships are full of “corruption” is both wrong and irresponsible.

Will Trump’s Pharma Shaming Bring Down Drug Prices? Not Likely, Poll Says

President Trump promised “voluntary massive drops in prices” from Big Pharma. Americans are skeptical.

An Unwarranted Attack On Rare Disease Research

Hearing a parent agonize over the plight of their child who suffers from a rare disease is heart wrenching. For these families, research into rare disease drugs hasn’t come close to “reaching an extreme”.

Pfizer Drug Reduces Death Rate In Patients With Hearts Damaged By Protein Clumps

An experimental Pfizer drug extended the lives of patients who had a disease in which clumps of protein break apart into toxic substances that damage the heart.

Pfizer Drug Reduces Death Rate In Patients With Hearts Damaged By Protein Clumps

An experimental Pfizer drug extended the lives of patients who had a disease in which clumps of protein break apart into toxic substances that damage the heart.

FDA’s New Generic EpiPen Approval Exemplifies Progress on Drug Price Reform

Last week, FDA Commissioner Scott Gottlieb announced the approval of the first generic version of EpiPen, an injectable form of epinephrine used in children to treat life-threatening allergies. Under Gottlieb and HHS Secretary Alex Azar, the consistent…